Genetic analysis of inherited bone marrow failure syndromes from one prospective, comprehensive and population-based cohort and identification of novel mutations

E. Tsangaris, R. Klaassen, C. V. Fernandez, R. Yanofsky, Evan Shereck, J. Champagne, M. Silva, J. H. Lipton, J. Brossard, B. Michon, S. Abish, M. Steele, K. Ali, N. Dower, U. Athale, L. Jardine, J. P. Hand, I. Odame, P. Canning, C. Allen & 4 others M. Carcao, J. Beyene, C. M. Roifman, Y. Dror

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Introduction Inherited bone marrow failure syndromes (IBMFSs) often have substantial phenotypic overlap, thus genotyping is often critical for establishing a diagnosis. Objectives and methods: To determine the genetic characteristics and mutation profiles of IBMFSs, a comprehensive population-based study that prospectively enrols all typical and atypical cases without bias is required. The Canadian Inherited Marrow Failure Study is such a study, and was used to extract clinical and genetic information for patients enrolled up to May 2010. Results: Among the 259 primary patients with IBMFS enrolled in the study, the most prevalent categories were DiamondeBlackfan anaemia (44 patients), Fanconi anaemia (39) and ShwachmaneDiamond syndrome (35). The estimated incidence of the primary IBMFSs was 64.5 per 106 births, with Fanconi anaemia having the highest incidence (11.4 cases per 106 births). A large number of patients (70) had haematological and non-haematological features that did not fulfil the diagnostic criteria of any specific IBMFS category. Disease-causing mutations were identified in 53.5% of the 142 patients tested, and in 16 different genes. Ten novel mutations in SBDS, RPL5, FANCA, FANCG, MPL and G6PT were identified. The most common mutations were nonsense (31 alleles) and splice site (28). Genetic heterogeneity of most IBMFSs was evident; however, the most commonly mutated gene was SBDS, followed by FANCA and RPS19. Conclusion: From this the largest published comprehensive cohort of IBMFSs, it can be concluded that recent advances have led to successful genotyping of about half of the patients. Establishing a genetic diagnosis is still challenging and there is a critical need to develop novel diagnostic tools.

Original languageEnglish (US)
Pages (from-to)618-628
Number of pages11
JournalJournal of Medical Genetics
Volume48
Issue number9
DOIs
StatePublished - Sep 2011
Externally publishedYes

Fingerprint

Mutation
Population
Fanconi Anemia
Parturition
Genetic Heterogeneity
Nonsense Codon
Incidence
Bone Marrow failure syndromes
Genes
Anemia
Bone Marrow
Alleles

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Genetic analysis of inherited bone marrow failure syndromes from one prospective, comprehensive and population-based cohort and identification of novel mutations. / Tsangaris, E.; Klaassen, R.; Fernandez, C. V.; Yanofsky, R.; Shereck, Evan; Champagne, J.; Silva, M.; Lipton, J. H.; Brossard, J.; Michon, B.; Abish, S.; Steele, M.; Ali, K.; Dower, N.; Athale, U.; Jardine, L.; Hand, J. P.; Odame, I.; Canning, P.; Allen, C.; Carcao, M.; Beyene, J.; Roifman, C. M.; Dror, Y.

In: Journal of Medical Genetics, Vol. 48, No. 9, 09.2011, p. 618-628.

Research output: Contribution to journalArticle

Tsangaris, E, Klaassen, R, Fernandez, CV, Yanofsky, R, Shereck, E, Champagne, J, Silva, M, Lipton, JH, Brossard, J, Michon, B, Abish, S, Steele, M, Ali, K, Dower, N, Athale, U, Jardine, L, Hand, JP, Odame, I, Canning, P, Allen, C, Carcao, M, Beyene, J, Roifman, CM & Dror, Y 2011, 'Genetic analysis of inherited bone marrow failure syndromes from one prospective, comprehensive and population-based cohort and identification of novel mutations', Journal of Medical Genetics, vol. 48, no. 9, pp. 618-628. https://doi.org/10.1136/jmg.2011.089821
Tsangaris, E. ; Klaassen, R. ; Fernandez, C. V. ; Yanofsky, R. ; Shereck, Evan ; Champagne, J. ; Silva, M. ; Lipton, J. H. ; Brossard, J. ; Michon, B. ; Abish, S. ; Steele, M. ; Ali, K. ; Dower, N. ; Athale, U. ; Jardine, L. ; Hand, J. P. ; Odame, I. ; Canning, P. ; Allen, C. ; Carcao, M. ; Beyene, J. ; Roifman, C. M. ; Dror, Y. / Genetic analysis of inherited bone marrow failure syndromes from one prospective, comprehensive and population-based cohort and identification of novel mutations. In: Journal of Medical Genetics. 2011 ; Vol. 48, No. 9. pp. 618-628.
@article{0040e3ef84a34b479e75e8620adb3093,
title = "Genetic analysis of inherited bone marrow failure syndromes from one prospective, comprehensive and population-based cohort and identification of novel mutations",
abstract = "Introduction Inherited bone marrow failure syndromes (IBMFSs) often have substantial phenotypic overlap, thus genotyping is often critical for establishing a diagnosis. Objectives and methods: To determine the genetic characteristics and mutation profiles of IBMFSs, a comprehensive population-based study that prospectively enrols all typical and atypical cases without bias is required. The Canadian Inherited Marrow Failure Study is such a study, and was used to extract clinical and genetic information for patients enrolled up to May 2010. Results: Among the 259 primary patients with IBMFS enrolled in the study, the most prevalent categories were DiamondeBlackfan anaemia (44 patients), Fanconi anaemia (39) and ShwachmaneDiamond syndrome (35). The estimated incidence of the primary IBMFSs was 64.5 per 106 births, with Fanconi anaemia having the highest incidence (11.4 cases per 106 births). A large number of patients (70) had haematological and non-haematological features that did not fulfil the diagnostic criteria of any specific IBMFS category. Disease-causing mutations were identified in 53.5{\%} of the 142 patients tested, and in 16 different genes. Ten novel mutations in SBDS, RPL5, FANCA, FANCG, MPL and G6PT were identified. The most common mutations were nonsense (31 alleles) and splice site (28). Genetic heterogeneity of most IBMFSs was evident; however, the most commonly mutated gene was SBDS, followed by FANCA and RPS19. Conclusion: From this the largest published comprehensive cohort of IBMFSs, it can be concluded that recent advances have led to successful genotyping of about half of the patients. Establishing a genetic diagnosis is still challenging and there is a critical need to develop novel diagnostic tools.",
author = "E. Tsangaris and R. Klaassen and Fernandez, {C. V.} and R. Yanofsky and Evan Shereck and J. Champagne and M. Silva and Lipton, {J. H.} and J. Brossard and B. Michon and S. Abish and M. Steele and K. Ali and N. Dower and U. Athale and L. Jardine and Hand, {J. P.} and I. Odame and P. Canning and C. Allen and M. Carcao and J. Beyene and Roifman, {C. M.} and Y. Dror",
year = "2011",
month = "9",
doi = "10.1136/jmg.2011.089821",
language = "English (US)",
volume = "48",
pages = "618--628",
journal = "Journal of Medical Genetics",
issn = "0022-2593",
publisher = "BMJ Publishing Group",
number = "9",

}

TY - JOUR

T1 - Genetic analysis of inherited bone marrow failure syndromes from one prospective, comprehensive and population-based cohort and identification of novel mutations

AU - Tsangaris, E.

AU - Klaassen, R.

AU - Fernandez, C. V.

AU - Yanofsky, R.

AU - Shereck, Evan

AU - Champagne, J.

AU - Silva, M.

AU - Lipton, J. H.

AU - Brossard, J.

AU - Michon, B.

AU - Abish, S.

AU - Steele, M.

AU - Ali, K.

AU - Dower, N.

AU - Athale, U.

AU - Jardine, L.

AU - Hand, J. P.

AU - Odame, I.

AU - Canning, P.

AU - Allen, C.

AU - Carcao, M.

AU - Beyene, J.

AU - Roifman, C. M.

AU - Dror, Y.

PY - 2011/9

Y1 - 2011/9

N2 - Introduction Inherited bone marrow failure syndromes (IBMFSs) often have substantial phenotypic overlap, thus genotyping is often critical for establishing a diagnosis. Objectives and methods: To determine the genetic characteristics and mutation profiles of IBMFSs, a comprehensive population-based study that prospectively enrols all typical and atypical cases without bias is required. The Canadian Inherited Marrow Failure Study is such a study, and was used to extract clinical and genetic information for patients enrolled up to May 2010. Results: Among the 259 primary patients with IBMFS enrolled in the study, the most prevalent categories were DiamondeBlackfan anaemia (44 patients), Fanconi anaemia (39) and ShwachmaneDiamond syndrome (35). The estimated incidence of the primary IBMFSs was 64.5 per 106 births, with Fanconi anaemia having the highest incidence (11.4 cases per 106 births). A large number of patients (70) had haematological and non-haematological features that did not fulfil the diagnostic criteria of any specific IBMFS category. Disease-causing mutations were identified in 53.5% of the 142 patients tested, and in 16 different genes. Ten novel mutations in SBDS, RPL5, FANCA, FANCG, MPL and G6PT were identified. The most common mutations were nonsense (31 alleles) and splice site (28). Genetic heterogeneity of most IBMFSs was evident; however, the most commonly mutated gene was SBDS, followed by FANCA and RPS19. Conclusion: From this the largest published comprehensive cohort of IBMFSs, it can be concluded that recent advances have led to successful genotyping of about half of the patients. Establishing a genetic diagnosis is still challenging and there is a critical need to develop novel diagnostic tools.

AB - Introduction Inherited bone marrow failure syndromes (IBMFSs) often have substantial phenotypic overlap, thus genotyping is often critical for establishing a diagnosis. Objectives and methods: To determine the genetic characteristics and mutation profiles of IBMFSs, a comprehensive population-based study that prospectively enrols all typical and atypical cases without bias is required. The Canadian Inherited Marrow Failure Study is such a study, and was used to extract clinical and genetic information for patients enrolled up to May 2010. Results: Among the 259 primary patients with IBMFS enrolled in the study, the most prevalent categories were DiamondeBlackfan anaemia (44 patients), Fanconi anaemia (39) and ShwachmaneDiamond syndrome (35). The estimated incidence of the primary IBMFSs was 64.5 per 106 births, with Fanconi anaemia having the highest incidence (11.4 cases per 106 births). A large number of patients (70) had haematological and non-haematological features that did not fulfil the diagnostic criteria of any specific IBMFS category. Disease-causing mutations were identified in 53.5% of the 142 patients tested, and in 16 different genes. Ten novel mutations in SBDS, RPL5, FANCA, FANCG, MPL and G6PT were identified. The most common mutations were nonsense (31 alleles) and splice site (28). Genetic heterogeneity of most IBMFSs was evident; however, the most commonly mutated gene was SBDS, followed by FANCA and RPS19. Conclusion: From this the largest published comprehensive cohort of IBMFSs, it can be concluded that recent advances have led to successful genotyping of about half of the patients. Establishing a genetic diagnosis is still challenging and there is a critical need to develop novel diagnostic tools.

UR - http://www.scopus.com/inward/record.url?scp=80052580675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052580675&partnerID=8YFLogxK

U2 - 10.1136/jmg.2011.089821

DO - 10.1136/jmg.2011.089821

M3 - Article

VL - 48

SP - 618

EP - 628

JO - Journal of Medical Genetics

JF - Journal of Medical Genetics

SN - 0022-2593

IS - 9

ER -